🔎 Trials Near Me

Почетна › Рак јајника › Kalifornija

Kliničke studije za Рак јајника u državi Kalifornija

109 studija za Рак јајника traži učesnike na lokacijama u državi Kalifornija.

Gradovi u državi Kalifornija

Zvanični tekst studije (na engleskom)

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • Cedars-Sinai Medical Center, Los Angeles
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
  • и још 1
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07001748

A Study to Evaluate OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.

  • UCSF - Helen Diller Family Comprehensive Cancer Center, San Francisco
Тражи се учесникФаза 1
Узраст 18 и старији · Жене · Ажурирано 12. 11. 2026. · NCT07664735

A Phase I/II, First-in-Human Study to Evaluate TJ102 in Participants With Advanced or Metastatic Ovarian Cancer and Other Solid Tumors.

  • South Texas Accelerated Research Therapeutics START LLC, Los Angeles
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07778498

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • PCR Oncology, Arroyo Grande
  • Mercy Cancer Center - Carmichael, Carmichael
  • Mercy San Juan Medical Center, Carmichael
  • и још 15
Тражи се учесникФаза 2
Сви узрасти · Оба пола · Ажурирано 12. 11. 2026. · NCT05564377

A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)

  • MemorialCare Orange Coast Medical Center ( Site 0032), Fountain Valley
Тражи се учесникФаза 3
Узраст 18 и старији · Жене · Ажурирано 10. 11. 2026. · NCT07743164

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

  • City of Hope Comprehensive Cancer Center ( Site 0007), Duarte
  • City of Hope Lennar Foundation Cancer Center ( Site 0024), Irvine
  • UCSF Medical Center at Mission Bay ( Site 0013), San Francisco
  • и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Жене · Ажурирано 10. 11. 2026. · NCT06824467

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

  • UCSD Moores Cancer Center ( Site 0038), La Jolla
  • John Muir Health Cancer Center ( Site 0069), Walnut Creek
Тражи се учесникФаза 3
Узраст 18 и старији · Жене · Ажурирано 10. 11. 2026. · NCT07318558

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • Kaiser Permanente-Deer Valley Medical Center, Antioch
  • Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
  • Sutter Auburn Faith Hospital, Auburn
  • и још 87
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT06580314

A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression

  • Site 0110, Antioch
  • Site 0104, Beverly Hills
  • Site 0122, Fountain Valley
  • и још 2
Тражи се учесникФаза 3
Узраст 18 и старији · Жене · Ажурирано 9. 11. 2026. · NCT07546500

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

  • UC San Diego Health, La Jolla
  • Cedars Sinai Medical Center, Los Angeles
Тражи се учесникФаза 2
Узраст 18 и старији · Жене · Ажурирано 6. 11. 2026. · NCT06787612

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

  • Kaiser Permanente-Deer Valley Medical Center, Antioch
  • Tower Cancer Research Foundation, Beverly Hills
  • Keck Medicine of USC Buena Park, Buena Park
  • и још 57
Тражи се учесник
Узраст од 35 до 50 · Жене · Ажурирано 6. 11. 2026. · NCT04251052

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Kaiser Permanente-Division of Research, Pleasanton
  • Naval Medical Center -San Diego, San Diego
Тражи се учесникЗдраве особе су добродошле
Узраст од 45 до 75 · Оба пола · Ажурирано 6. 11. 2026. · NCT06995898

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

  • University of California - Los Angeles, Los Angeles
Тражи се учесникФаза 1
Узраст 19 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT06586957

INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study

  • University of California Los Angeles (UCLA), Los Angeles
Тражи се учесникНаводи исплату за учеснике
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07671937

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • City of Hope National Medical Center, Duarte
  • University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
  • UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06465069

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  • Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center, Burbank
  • City of Hope, Duarte, Duarte
  • City of Hope Lennar, Irvine
  • и још 6
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07213804

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • City of Hope, Duarte
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст 40 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT05366881

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  • University of California Los Angeles Medical Center, Los Angeles
  • University of California, San Diego; Moores Cancer Center, San Diego
  • USOR Sansum Clinic, Santa Barbara
  • и још 1
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT05579366

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

  • University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06400472

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

  • Hoag Memorial Hospital Presbyterian, Newport Beach
  • Stanford University Medical Center, Stanford
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07213791

Distance-Based Exercise to Preserve Function and Prevent Disability

  • Kaiser Permanente Dublin, Dublin
  • Kaiser Permanente-Fremont, Fremont
  • Kaiser Permanente Fresno Orchard Plaza, Fresno
  • и још 10
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07059884

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  • City of Hope - Duarte Cancer Center, Duarte
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06760819

Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer

  • City of Hope, Duarte
Тражи се учесникФаза 3
Узраст 18 и старији · Жене · Ажурирано 4. 11. 2026. · NCT07564141

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

  • START Los Angeles, Los Angeles
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT07524322

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

  • USA06-0, Los Angeles
  • USA16-0, Los Angeles
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06953089

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  • City of Hope, Duarte
  • City of Hope, Irvine, Irvine
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07109726

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

  • Disney Family Cancer Center, Burbank
  • Scripps Clinic, La Jolla
  • Palo Alto Medical Foundation, Palo Alto
Тражи се учесникФаза 3
Узраст 18 и старији · Жене · Ажурирано 28. 10. 2026. · NCT06819007

Lead-212 PSV359 Therapy for Patients With Solid Tumors

  • VA Greater Los Angeles Healthcare System, Los Angeles
  • UCLA Department of Medicine - Hematology/Oncology, Los Angeles
Тражи се учесникФаза 1/2
Узраст од 18 до 90 · Оба пола · Ажурирано 28. 10. 2026. · NCT06710756

A Study of MGC026 in Participants With Advanced Solid Tumors

  • The Angeles Clinic and Research Institute, Los Angeles
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT06242470

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  • Los Angeles Cancer Network, Los Angeles
  • Pih Health Hematology Medical Oncology, Whittier
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06330064

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • University of California San Diego, La Jolla
  • Stanford University, Palo Alto
  • UCLA Medical Center, Santa Monica
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT04981119

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • City of Hope, Duarte
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06172478

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  • USC Norris Comprehensive Cancer Center, Los Angeles
  • Providence Medical Foundation, Santa Rosa
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT04657068

AOH1996 for the Treatment of Refractory Solid Tumors

  • City of Hope Medical Center, Duarte
  • City of Hope at Long Beach Elm, Long Beach
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT05227326

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

  • Kaiser Permanente - Irvine /ID# 276924, Irvine
  • UCLA - University of California Los Angeles Medical Center /ID# 274566, Los Angeles
  • Scripps Md Anderson - Prebys Cancer Center /ID# 276891, San Diego
  • и још 1
Тражи се учесникФаза 2
Узраст 18 и старији · Жене · Ажурирано 20. 10. 2026. · NCT06890338

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  • University of Southern California, Los Angeles
  • Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
  • Cedars-Sanai Medical Center, Los Angeles
  • и још 2
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT06582017

A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer

  • City of Hope at Arcadia, Arcadia
  • City of Hope Medical Center, Duarte
  • City of Hope at Seacliff, Huntington Beach
  • и још 8
Тражи се учесник
Узраст 18 и старији · Жене · Ажурирано 16. 10. 2026. · NCT07741968

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  • City of Hope Medical Center, Duarte
  • Valkyrie Clinical Trials, Los Angeles
Тражи се учесникФаза 3
Узраст 18 и старији · Жене · Ажурирано 15. 10. 2026. · NCT07214779

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer

  • City of Hope National Medical Center /ID# 281381, Duarte
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 280914, Irvine
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT07278336

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

  • UC San Diego Health - Moores Cancer Center /ID# 277574, La Jolla
Тражи се учесникФаза 2
Узраст 18 и старији · Жене · Ажурирано 13. 10. 2026. · NCT07059845

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.